
Kaminari Medical
PROBLEM Insufficient treatment of vulnerable plaque in the coronary arteries lead to costly and health impairing re-catheterizations In 2015, Coronary Artery Disease (CAD) affected 110 million people and resulted in 8.9 million deaths worldwide. CAD occurs when the arteries that supply the heart muscle with blood become hardened and narrowed, due to the buildup of cholesterol and plaque on their inner walls. Current treatment: To open the blocked coronary arteries, 80% of the patients are treated using a Percutaneous Coronary Intervention (PCI). - Of those patients treated with PCI, 12% get a re-catheterization within 12 months after the initial procedure. - Total costs for these re-catheterizations are estimated at $ 3,5 billion. 50% of these re-catheterizations are caused by a type of stenosis called vulnerable plaques, that are formed by fat-filled cells with a thin cover. If the cover ruptures a blood clot is formed, blocking the coronary artery. - If these vulnerable plaques were treated in an early stage, repeat catheterizations could be prevented. SOLUTION Kaminari combines ultrasound (IVUS) and photoacoustic (PA) imaging, providing better information on both plaque location and composition. Visit our website for more details.

Kaminari Medical
The company provides intravascular imaging technology combining IVPA and IVUS to improve coronary artery disease diagnosis and treatment.
About
Needs Assessment
Active buying signals and potential business opportunities
Technology Requirements
Intravascular imaging technology
Imaging technology for coronary artery disease
Service Requirements
Regulatory and quality management system support
Clinical Sciences and Research and Development and Product Development
Better assessment of coronary arteries
Infrastructure Requirements
Catheter for eventual use in patients.
Requires catheter and imaging system.
AI Insights
Growth Trajectory
The company's €3.8M funding round and ongoing product development signal strong growth potential in the intravascular imaging market.
Market Opportunity
The company has a strong market opportunity in addressing the unmet need for visualizing lipid-rich plaques, positioning them as an innovator in cardiovascular diagnostics.
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats